icon-folder.gif   Conference Reports for NATAP  
 
  15th International Workshop on
Clinical Pharmacology
of HIV and Hepatitis Therapy
May 19- 21, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
PHARMACOKINETICS OF SIMEPREVIR, JNJ-56914845 AND
RITONAVIR-BOOSTED TMC647055 WHEN CO-ADMINISTERED IN HEALTHY VOLUNTEERS

 
 
  Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy. Washington DC, May 19-21, 2014
 
T.N. Kakuda,1 K. Spittaels,2 R. Verloes,2 I. Vanwelkenhuysen,3 C. Truyers,2 P. Van Remoortere1
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases, BVBA, Beerse, Belgium; 3Janssen Research & Development NV, Beerse, Belgium

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif